Anna Hopkins

Title: Anna Hopkins: Innovator in Pharmaceutical Compounds

Introduction

Anna Hopkins is a distinguished inventor based in Saffron Walden, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications. With a total of 2 patents, her work focuses on innovative solutions for medical challenges.

Latest Patents

Among her latest patents, Anna has developed Factor XIIA inhibitors. This invention relates to compounds of formula (I) and methods of treatment using these compounds. The invention also encompasses processes and methods for producing the compounds, which serve as modulators of Factor XII, specifically as inhibitors of Factor XIIa. These compounds may be useful as anticoagulants. Another notable patent involves inhibitors of RAS-effector protein interactions. This invention pertains to compounds of Formula I, including their salts and solvates. It also relates to pharmaceutical compositions comprising these compounds, which are intended for the treatment of proliferative disorders, such as cancer, and other diseases where inhibition of a RAS-effector protein-protein interaction is implicated.

Career Highlights

Anna has worked with reputable institutions, including the University of Leeds and Oxford University Innovation Limited. Her experience in these organizations has allowed her to advance her research and contribute to the scientific community.

Collaborations

Anna has collaborated with notable individuals in her field, including Philip Spencer Fallon and Natalie Louise Winfield. These partnerships have enriched her work and expanded the impact of her inventions.

Conclusion

Anna Hopkins is a remarkable inventor whose work in pharmaceutical compounds demonstrates her commitment to advancing medical science. Her innovative patents and collaborations highlight her significant contributions to the field.